Does NIVOLUMAB Cause Increased appetite? 57 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 57 reports of Increased appetite have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.
57
Reports of Increased appetite with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
3
Deaths
20
Hospitalizations
How Dangerous Is Increased appetite From NIVOLUMAB?
Of the 57 reports, 3 (5.3%) resulted in death, 20 (35.1%) required hospitalization, and 1 (1.8%) were considered life-threatening.
Is Increased appetite Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 57 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Increased appetite?
SEMAGLUTIDE (980)
RISPERIDONE (808)
TIRZEPATIDE (640)
OLANZAPINE (556)
ARIPIPRAZOLE (465)
QUETIAPINE (389)
RUXOLITINIB (287)
PREDNISONE (265)
PREGABALIN (265)
GABAPENTIN (253)
Which NIVOLUMAB Alternatives Have Lower Increased appetite Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE